Inventor · disambiguated record
Keith B. Gorden
Also filed as: GORDEN KEITH · GORDEN KEITH B
9 granted patents·17 pending applications·206 citations·filing 2002–2024
88Inventor score
Top patents by PatentIndex Score
26 records- 0194US7375180B2Methods and compositions related to IRM compounds and Toll-like receptor 83M INNOVATIVE PROPERTIES CO·Filed 2004·Granted May 20, 2008·121 cites·17 claims
- 0290US7485432B2Selective modulation of TLR-mediated biological activity3M INNOVATIVE PROPERTIES CO·Filed 2004·Granted Feb 3, 2009·65 cites·9 claims
- 0389US10114027B2Beta-glucan assay methodsBIOTHERA INC·Filed 2017·Granted Oct 30, 2018·3 cites·19 claims
- 0486US10111901B2Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·4 cites·19 claims
- 0584US10111900B2β-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·3 cites·20 claims
- 0682US9885726B2β-glucan assay methodsBIOTHERA INC·Filed 2014·Granted Feb 6, 2018·3 cites·20 claims
- 0782US2025009782A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0881US2025114392A1Beta-glucan in combination with anti-cancer agents affecting the tumor micrenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0980US2024350528A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2023·Application pending·0 cites
- 1079US9943607B2Beta-glucan compounds, compositions, and methodsBOSE NANDITA·Filed 2012·Granted Apr 17, 2018·3 cites·22 claims
- 1179US9694070B2Compositions including β-glucans and methods of useGORDEN KEITH B·Filed 2012·Granted Jul 4, 2017·4 cites·31 claims
- 1279US2025114391A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 1374US2023172967A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2022·Application pending·0 cites
- 1473US2022117998A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1568US2022047620A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1667US2021283169A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1765US2019064179A1Beta-glucan assay methodsBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1863US2019060350A1Beta-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1962US2019022129A1Beta-glucan immunotherapies affecting the immune microenvironmentBIOTHERA INC·Filed 2017·Application pending·0 cites
- 2062US2019060351A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2160US10166289B2Compositions including beta-glucans and method of useBIOTHERA INC·Filed 2017·Granted Jan 1, 2019·0 cites·20 claims
- 2256US2018256738A1Beta-glucan compounds, compositions, and methodsBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2349US2005245564A1Methods and compositions related to IRM compounds and toll-like receptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 2447US2004014779A1Methods and compositions related to IRM compounds and toll-like recptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2002·Application pending·0 cites
- 2547US2010113565A1Immunostimulatory combinations and methodsGORDEN KEITH B·Filed 2005·Application pending·0 cites
- 2644US2011070575A1Immunomodulatory Compositions, Combinations and MethodsCOLEY PHARM GROUP INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Keith B. Gorden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →